ORIGINAL CONTRIBUTION. Infratentorial Lesions Predict Long-term Disability in Patients With Initial Findings Suggestive of Multiple Sclerosis
|
|
- Everett Griffin
- 5 years ago
- Views:
Transcription
1 ORIGINAL CONTRIBUTION Infratentorial Lesions Predict Long-term Disability in Patients With Initial Findings Suggestive of Multiple Sclerosis Arjan Minneboo, MD; Frederick Barkhof, MD; Chris H. Polman, MD; Bernard M. J. Uitdehaag, MD; Dirk L. Knol, PhD; Jonas A. Castelijns, MD Background: The number and volume of abnormalities on baseline brain magnetic resonance images in patients with initial findings suggestive of multiple sclerosis are known to predict outcome in terms of disability. However, no long-term data exist on specific locations or types of lesions. Objective: To assess the long-term predictive value of baseline magnetic resonance imaging parameters, including location of lesions and gadolinium-enhancing and hypointense lesions in patients with initial findings suggestive of multiple sclerosis for the occurrence of clinically relevant disability as defined by an Expanded Disability Status Scale score of 3. Patients: After a median follow-up period of 8.7 years, the medical records of 42 patients were reviewed and assessed for time until patients received an Expanded Disability Status Scale score of 3. Magnetic resonance imaging parameters were dichotomized according to maximum accuracy and then used to calculate hazard ratios using the Cox model for proportional hazard ratios. Results: Conversion to clinically definite multiple sclerosis was observed in 26 patients (62%), of whom 14 (54%) progressed to an Expanded Disability Status Scale score of 3. Two or more infratentorial lesions best predicted long-term disability (hazard ratio, 6.3). Gadolinium-enhancing and hypointense T1-weighted lesions did not show prognostic value. Conclusion: Infratentorial lesions are related to longterm prognosis for patients with initial findings suggestive of multiple sclerosis and thus may help to identify patients at high risk for earlier occurrence of clinically relevant disability. Arch Neurol. 2004;61: From the Departments of Radiology (Drs Minneboo, Barkhof, and Castelijns), Neurology (Drs Polman and Uitdehaag), and Clinical Epidemiology and Biostatistics (Drs Uitdehaag and Knol), MR Center for MS Research, VU Medical Center, Amsterdam, the Netherlands. INITIAL FINDINGS IN PATIENTS WHO eventually develop multiple sclerosis (MS) usually indicate a clinically isolated syndrome, although multisymptomatic onset does occur in a significant subset of patients. For these patients, there are 2 major concerns: the risk of development of clinically definite (CD) MS, and the prognosis with regard to disability if CDMS develops. Therefore, it would be desirable to have a model that estimates the risk of developing MS and accompanying disability, especially now that there is evidence that some patients will benefit from treatment in this early phase of the disease. 1,2 Several studies have shown the value of magnetic resonance imaging (MRI) in predicting the development of CDMS. 3-8 Long-term follow-up studies demonstrate a conversion rate to CDMS of 35% to 80%. 4,5,7,9-11 With the use of MRI, there is significant diagnostic gain. At their initial examination, most patients already have multiple white matter lesions on T2- weighted MRIs of the brain. The sensitivity, specificity, and accuracy differ between the proposed criteria. However, the prediction of longterm disability is far more uncertain. Several studies described the significant relationship between lesion load at baseline and the Expanded Disability Status Scale (EDSS) score at 5 years follow-up, which was also found after 14 years of follow-up. 4,8,12 Morrissey et al 7 and O Riordan et al 13 reported on the 5- and 10-year follow-up results in patients who were initially found to have optic neuritis, brainstem syndrome, or incomplete spinal cord syndrome. After 5 years, 20% had received an EDSS score greater than or equal to 3, whereas after 10 years, 30% showed progression to an EDSS score greater than 3. The type of initial symptoms seems to be important in this context: patients initially exhibiting optic neuritis are reported to have a low risk of reaching an EDSS score of 3 after a follow-up of 5 (4%) 14 or even 15 (10%) years. 10 The outcome of patients initially exhibit- 217
2 Table 1. Conversion to CDMS and Progression to an EDSS Score of 3 as Classified by Initial Findings* Initial Findings No. of Patients CDMS EDSS 3 Optic neuritis (67) 5 (28) Brainstem/cerebellar syndrome 6 4 (67) 3 (50) Spinal cord syndrome 4 3 (75) 1 (25) Brain syndrome 6 2 (33) 1 (17) Multisymptomatic 8 5 (63) 4 (50) Total (62) 14 (33) Abbreviations: CDMS, clinically definite MS (according to the Poser criteria 17 ); EDSS, Expanded Disability Status Scale. *Data are given as number (percentage) of patients unless otherwise indicated. ing a spinal cord syndrome appears to be worse: 20% of these patients reach an EDSS score greater than or equal to 3 within 3.5 years. 9 Not only the presence or absence of lesions but also the location of lesions might be predictive of long-term disability. The presence of lesions in the infratentorial region on the baseline scan has been reported to correlate with EDSS score at follow-up 8,12 and is likely one of the major predictive factors. In the studies mentioned so far, the predictive value of T1-weighted MRI parameters, such as gadolinium-enhancing and hypointense lesions for long-term disability has not been studied, and location of the lesions on T2-weighted images was only scored as supratentorial or infratentorial. In this study, we present the long-term follow-up results in a group of patients with a first episode of neurologic dysfunction suggestive of MS. To determine the prognostic value of baseline brain MRI findings in predicting the development of disability (EDSS score 3), we tested several MRI criteria, including gadoliniumenhancing and hypointense lesions on T1-weighted images and location of the lesions on T2-weighted images. METHODS PATIENTS Forty-two patients (25 female, 17 male; female-male ratio, 1.5) with a first episode of neurologic dysfunction suggestive of MS were included. At initial examination, the mean age was 31.8 years (range, years). Eighteen patients had optic neuritis, 6 patients had a brainstem or cerebellar syndrome, 6 patients had a brain syndrome (hemimotor and/or hemisensory syndrome), 4 patients had a spinal cord syndrome, and 8 patients were multisymptomatic. All patients were referred by neurologists and ophthalmologists before November The patients are part of a larger cohort (n=59), from which findings have been reported previously. 15,16 These previous studies described 10 patients in whom a diagnosis other than MS was ultimately made and 7 patients who were lost to follow-up. In the present study, medical records of the remaining 42 cases were reviewed by a single neurologist (C.H.P.) who was unaware of any MRI results. The following clinical parameters were assessed: initial symptom(s), date of conversion to CDMS, and date at which EDSS scores of 3 and 6 were reached. The EDSS thresholds were chosen because they represent the first and second major meaningful milestones of disability. The diagnosis of CDMS was made according to the criteria of Poser et al. 17 MAGNETIC RESONANCE IMAGING Magnetic resonance imaging had been performed on a 0.6-T machine before November Axial T2- and T1-weighted spinecho images (repetition time/echo time/number of signals acquired, 2755/60120/2 and 450/28/4, respectively) were obtained. Each series consisted of 19 sections with a section thickness of 5 mm (1.25-mm gap), covering the whole brain. The T1- weighted spin-echo series was performed 5 to 10 minutes after the administration of 0.1 mmol/kg of gadolinium pentetic acid. The MRIs were analyzed by consensus during a single session in which 2 observers were blinded to the clinical findings (as described earlier 16 ). The following items were scored: the total number of (hyperintense) T2-weighted lesions, T2- weighted lesions greater than 6 mm, and the number of frontal, parietal, temporal, occipital, infratentorial, basal ganglia/ internal capsule, periventricular, (juxta)cortical, and callosal/ subcallosal lesions seen on T2-weighted MRI. On T1- weighted MRI, the number of enhancing (total and large 6 mm) and hypointense lesions were scored. STATISTICAL ANALYSIS Based on the clinical data, patients were classified as having no or minimal disability (EDSS score 3) or clinically relevant disability (EDSS score 3). Using progression to an EDSS score of 3 as the outcome, the accuracy of different cutoff levels was calculated for each MRI criterion. Final dichotomization for each MRI criterion was based on maximum accuracy. The data were analyzed using proportional hazards regression according to the Cox model (likelihood ratio 2 test). Progression to an EDSS score of 3 was used as the dependent variable, while the dichotomized MRI criteria were used as independent variables. Univariate analyses were performed for each of the MRI criteria, and all MRI criteria were then explored together in a forward stepwise regression analysis to find the strongest predictive model. RESULTS The median duration of follow-up was 8.7 years (interquartile range [IQR], years). In 26 patients (62%), a second attack occurred, and the diagnosis of CDMS was made (Table 1). The female-male ratio was 1.5. Fourteen (54%) of 26 CDMS patients progressed to clinically significant disability as marked by an EDSS score greater than or equal to 3. The median time to reach an EDSS score greater than or equal to 3 was 6.4 years (IQR, years). Only 5 patients (19%) reached an EDSS score greater than or equal to 6, which precluded the use of this parameter as an outcome variable for statistical analysis. T2-weighted MRIs showed 1 or more lesions in 34 patients (81%). The median number of lesions was 6.5 (IQR, ) (Table 2). Most lesions were seen in the frontal lobes (median, 2.5; IQR, ) and periventricularly (median, 2.0; IQR, ). Relatively low numbers of lesions were seen infratentorially (median, 0; IQR, 0-2.0) and in the basal ganglia or internal capsula (median, 0; IQR, 0-0.3). Strong internal correlations were found among the various MRI criteria on T2- weighted images (data not shown). Four of 5 patients who 218
3 Table 2. Magnetic Resonance Imaging Findings Total No. of Patients CDMS Patients Median Criterion Median Range IQR Range IQR T2-weighted images Total No. of lesions Periventricular lesions Callosal lesions Frontal lesions Parietal lesions Occipital lesions Temporal lesions Infratentorial lesions Basal ganglia/internal capsule (Juxta) cortical lesions Lesions 6 mm T1-weighted images Hypointense lesions Gadolinium-enhancing lesions Gadolinium-enhancing lesions 6 mm Abbreviations: CDMS, clinically definite multiple sclerosis (according to the criteria of Poser et al 17 ); IQR, interquartile range. reached an EDSS score of 6 had infratentorial lesions; 3 of these had at least 2 lesions (data not shown). The number of infratentorial lesions and the total number of lesions was high in patients with spinal cord syndrome (median, 33.5 and 2.5, respectively) and low in patients with optic neuritis (median, 3.5 and 0, respectively). At follow-up, no significant relationship was found between the presence of 1 or more lesions on T2- weighted images and an EDSS score of 3 (not dichotomized for maximum accuracy), a hazard ratio of 2.4, and P=.4 (not tabulated). After dichotomizing according to maximum accuracy, a high hazard ratio (6.8) was found for the total number of T2-weighted lesions, with a cutoff level of at least 9 lesions (Table 3). All dichotomized MRI criteria regarding location were significantly related to progression to an EDSS score of 3, with hazard ratios varying between 3.1 and 7.2. We did not find the predictive value of MRI criteria on T1-weighted images. Despite dichotomizing according to maximum accuracy, gadoliniumenhancing lesions (both small and large) and hypointense lesions did not show a statistically significant relationship to progression to an EDSS score of 3. Finally, we performed forward stepwise proportional hazards regression. Using the time to reach an EDSS score of 3 as the dependent variable revealed that the presence of at least 2 infratentorial lesions was the best predictor (likelihood ratio 2 test, 11.27; P=.001). Adding more criteria did not result in significant improvement of the model, possibly owing to strong correlations between evaluated MRI criteria. Patients with at least 2 infratentorial lesions had a worse outcome at follow-up as measured by the percentage of patients who showed progression to an EDSS score of 3 (Figure). COMMENT We found that several MRI criteria derived from T2- weighted images were related to the development of clinically relevant disability as defined by an EDSS score of 3. Having at least 2 infratentorial lesions proved to be the best predictor. Criteria derived from T1-weighted images were not associated with the time to reach an EDSS score of 3. Even though case ascertainment was not complete, the group of patients included in this study seems to be representative. After a median follow-up of about 9 years, the rate of conversion to CDMS (62%) and the development of disability were in accordance with data known from other long-term follow-up studies in comparable patient groups. 13,18 This is also valid for the number of abnormal scans ( 1 lesions) and number of lesions found. No significant hazard ratio was found for an abnormal MRI finding ( 1 lesion on T2-weighted imaging): although sensitive, the presence of 1 or more T2-weighted lesions is not a useful prognostic factor with respect to development of disability. We aimed at increasing the predictive value of lesions by not only counting them, but also taking the location into account. This resulted in a significant hazard ratio for progression to an EDSS score of 3 for several parameters. A combination of high hazard ratio and high statistical significance (P=.002) was found for infratentorial, callosal, and periventricular lesions. Infratentorial lesions are thought to be relatively specific for MS ; the few studies that reported on the prevalence of infratentorial lesions in MS found these lesions in a percentage of patients ranging from 6% (Jacobs et al 5 in a study of patients with optic neuritis) to 40%. 12,18 Sailer et al 12 found a higher mean EDSS score and a greater increase in total lesion volume after 10 years of follow-up for patients with 1 or more infratentorial lesions than for those without these lesions. They also found a significant correlation of the infratentorial lesion volume at baseline and EDSS score at 10 years. Our results confirm and extend these findings: in our final model only, infratentorial lesions are included as predictors of longterm disability. The other parameters, despite their good performance when tested in isolation, do not add independent information. 219
4 Table 3. Predictive Value of Dichotomized MRI Criteria for Progression to an EDSS Score of 3* MRI Criteria Cutoff Value Prevalence (n) LR 2 1 P Value Hazard Ratio T2-weighted images Total No. of lesions Periventricular lesions Callosal lesions Frontal lesions Parietal lesions Occipital lesions Temporal lesions Infratentorial lesions Basal ganglia or internal capsule (Juxta) cortical lesions Lesions 6 mm T1-weighted lesions Hypointense lesions Gadolinium enhancement Gadolinium-enhancing lesions 6 mm Abbreviations: EDSS, Expanded Disability Status Scale; LR, likelihood ratio; MRI, magnetic resonance imaging. *Magnetic resonance imaging criteria were dichotomized according to maximum accuracy (cutoff value) and subsequently, hazard ratios were calculated using the Cox model for proportional hazard ratios. Fraction of Patients With an EDSS Score < Infratentorial Lesions <2 Intratentorial Lesions Follow-up, y Percentage of patients with Expanded Disability Status Scale (EDSS) less than 3 at follow-up after dichotomizing for infratentorial lesions ( 2 vs 2 infratentorial lesions) and in relationship to the presence or absence of 2 or more infratentorial lesions. There are at least 2 possible explanations for the observed dominance of infratentorial lesions in predicting the development of disability. First, damage to structures in the infratentorial compartment is likely to have an important effect on clinical disability, as has been emphasized before. 22 Second, there is a close relationship between the spinal cord and the infratentorial compartment. The presence of infratentorial lesions may be an indicator for spinal cord disease, and the latter is known to correlate well with disability Even though the presence of gadolinium-enhancing lesions is probably one of the best predictive MRI parameters for the development of CDMS, 15,16,18,27 the relationship between gadolinium enhancement and the development of long-term disability is less clear. In a metaanalysis by Kappos et al, 28 both the baseline and monthly rates of gadolinium-enhanced MRI in MS patients were not predictive for the change in EDSS score in the following 1 or 2 years. These authors concluded that the presence of gadolinium-enhancing lesions is not a good predictor of long-term disability in patients with relapsingremitting and secondary progressive MS. Our data confirm that the predictive value of gadolinium enhancement in patients at their first disease manifestation with respect to future disability is also limited. Despite our search for optimal cutoff levels, none of the T1-weighted MRI parameters was related to the development of disability. In patients with MS, lesions that are hypointense on T1-weighted images are commonly seen, and it is suggested that they indicate severe tissue destruction and axonal loss. 29,30 Truyen et al 31 showed that the relationship to progression of disability in MS is stronger for hypointense T1-weighted lesions than for hyperintense T2- weighted lesions. In patients with a clinically isolated syndrome, hypointense lesions may also be found. Their predictive value for progression of disability in these patients is unknown, but Brex et al 18 found their presence to be associated with higher rates of new lesion formation at follow-up. Although T1-weighted infratentorial lesions may play a significant role later in the disease, 32 their predictive value at initial examination seems to be limited because in the early phase they are relatively sparse, as was the case in our patients. There are several limitations to our study. Based on the clinical data available for follow-up, we were not confident to decide on the exact moment of conversion of relapsing-remitting to secondary progressive MS for many patients, and therefore, we were unable to include this parameter in our analysis. In addition, MRI scans were performed many years before on a 0.6-T machine, and the results perhaps cannot be compared directly with results from high-resolution scanning protocols using 1.0- or 1.5-T machines. Owing to technical problems regarding the storage of the electronic MRI data, it also was not possible to obtain lesion loads and incorporate these quan- 220
5 titative data into our analyses. Furthermore, at the time of the first clinical examination, we did not routinely perform spinal cord imaging. Therefore, spinal cord abnormalities, potentially of great importance concerning disability development, could not be taken into account. The duration of follow-up in this study was such that the proportion of patients who reached an EDSS score of 6 was low, thereby preventing analysis of parameters predictive of more severe disability, although it may be speculated that there will be similarities with parameters correlated with moderate disability. In conclusion, we found that several MRI criteria derived from baseline T2-weighted images were strongly related to progression to an EDSS score of 3 at followup. The presence of at least 2 infratentorial lesions was found to be the strongest predictor of progression to an EDSS score of 3. We did not find any prognostic value of MRI criteria derived from T1-weighted images, such as gadolinium-enhancing lesions and hypointense lesions for progression to an EDSS score of 3. Longer follow-up is needed to determine the predictive value of these criteria for more severe disability. Accepted for publication September 18, Author contributions: Study concept and design (Drs Minneboo, Barkhof, Polman, and Castelijns); acquisition of data (Drs Minneboo, Barkhof, Polman, and Castelijns); analysis and interpretation of data (Drs Minneboo, Barkhof, Polman, Uitdehaag, Knol, and Castelijns ); drafting of the manuscript (Drs Minneboo, Barkhof, Polman, Uitdehaag, and Castelijns); critical revision of the manuscript for important intellectual content (Drs Minneboo, Barkhof, Uitdehaag, Knol, and Castelijns); statistical expertise (Drs Minneboo, Uitdehaag, and Knol); obtained funding (Drs Polman and Castelijns); administrative, technical, and material support (Drs Barkhof and Castelijns); study supervision (Drs Barkhof, Polman, Uitdehaag, and Castelijns). This study was supported by grant MS from the Dutch Foundation for the Support of MS Research (Dr Minneboo) and the Dutch Foundation for the Support of MS Research and the VU Medical Centre (MS-MRI center). Corresponding author: A. Minneboo, MD, VU Medical Centre, Department of Radiology, PO Box 7057, 1007 MB Amsterdam, the Netherlands ( a.minneboo@vumc.nl). REFERENCES 1. Comi G, Filippi M, Barkhof F, et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet. 2001;357: Jacobs LD, Beck RW, Simon JH, et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med. 2000;343: Beck RW, Cleary PA, Trobe JD, et al. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. N Engl J Med. 1993;329: Brex PA, Ciccarelli O, O Riordan JI, Sailer M, Thompson AJ, Miller DH. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med. 2002;346: Jacobs L, Munschauer FE, Kaba SE. Clinical and magnetic resonance imaging in optic neuritis. Neurology. 1991;41: Lee KH, Hashimoto SA, Hooge JP, et al. Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology. 1991;41: Morrissey SP, Miller DH, Kendall BE, et al. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis: a 5-year follow-up study. Brain. 1993; 116(pt 1): Filippi M, Horsfield MA, Morrissey SP, et al. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology. 1994;44: Ford B, Tampieri D, Francis G. Long-term follow-up of acute partial transverse myelopathy. Neurology. 1992;42: Rizzo JF III, Lessell S. Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long-term prospective study. Neurology. 1988;38: Sandberg-Wollheim M, Bynke H, Cronqvist S, Holtas S, Platz P, Ryder LP. A longterm prospective study of optic neuritis: evaluation of risk factors. Ann Neurol. 1990;27: Sailer M, O Riordan JI, Thompson AJ, et al. Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination. Neurology. 1999;52: O Riordan JI, Thompson AJ, Kingsley DP, et al. The prognostic value of brain MRI in clinically isolated syndromes of the CNS: a 10-year follow-up. Brain. 1998; 121(pt 3): Optic Neuritis Study Group. The 5-year risk of MS after optic neuritis: experience of the optic neuritis treatment trial. Neurology. 1997;49: Tas MW, Barkhol F, van Walderveen MA, Polman CH, Hommes OR, Valk J. The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis. AJNR Am J Neuroradiol. 1995;16: Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain. 1997; 120(pt 11): Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13: Brex PA, O Riordan JI, Miszkiel KA, et al. Multisequence MRI in clinically isolated syndromes and the early development of MS. Neurology. 1999;53: Caldemeyer KS, Smith RR, Harris TM, Edwards MK. MRI in acute disseminated encephalomyelitis. Neuroradiology. 1994;36: Miller DH, Ormerod IE, Gibson A, du Boulay EP, Rudge P, McDonald WI. MR brain scanning in patients with vasculitis: differentiation from multiple sclerosis. Neuroradiology. 1987;29: Sherman JL, Stern BJ. Sarcoidosis of the CNS: comparison of unenhanced and enhanced MR images. AJNR Am J Neuroradiol. 1990;11: Yousry TA, Grossman RI, Filippi M. Assessment of posterior fossa damage in MS using MRI. J Neurol Sci. 2000;172(suppl 1):S50-S Losseff NA, Webb SL, O Riordan JI, et al. Spinal cord atrophy and disability in multiple sclerosis: a new reproducible and sensitive MRI method with potential to monitor disease progression. Brain. 1996;119(pt 3): Nijeholt GJ, van Walderveen MA, Castelijns JA, et al. Brain and spinal cord abnormalities in multiple sclerosis: correlation between MRI parameters, clinical subtypes and symptoms. Brain. 1998;121(pt 4): Nijeholt GJ, Castelijns JA, Lazeron RH, et al. Magnetization transfer ratio of the spinal cord in multiple sclerosis: relationship to atrophy and neurologic disability. J Neuroimaging. 2000;10: Stevenson VL, Leary SM, Losseff NA, et al. Spinal cord atrophy and disability in MS: a longitudinal study. Neurology. 1998;51: MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group. Neurology. 2002;59: Kappos L, Moeri D, Radue EW, et al, for the Gadolinium MRI Meta-analysis Group. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a metaanalysis. Lancet. 1999;353: van Waesberghe JH, Kamphorst W, De Groot CJ, et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol. 1999;46: van Walderveen MA, Truyen L, van Oosten BW, et al. Development of hypointense lesions on T1-weighted spin-echo magnetic resonance images in multiple sclerosis: relation to inflammatory activity. Arch Neurol. 1999;56: Truyen L, van Waesberghe JH, van Walderveen MA, et al. Accumulation of hypointense lesions ( black holes ) on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology. 1996;47: Hickman SJ, Brierley CM, Silver NC, et al. Infratentorial hypointense lesion volume on T1-weighted magnetic resonance imaging correlates with disability in patients with chronic cerebellar ataxia due to multiple sclerosis. J Neurol Sci. 2001;187:
Isolated Demyelinating Syndromes: Comparison of Different MR Imaging Criteria to Predict Conversion to Clinically Definite Multiple Sclerosis
AJNR Am J Neuroradiol 21:702 706, April 2000 Isolated Demyelinating Syndromes: Comparison of Different MR Imaging Criteria to Predict Conversion to Clinically Definite Multiple Sclerosis Mar Tintoré, Alex
More informationThe prognostic value of brain MRI in clinically isolated syndromes of the CNS A 10-year follow-up
Brain (1998), 121, 495 503 The prognostic value of brain MRI in clinically isolated syndromes of the CNS A 10-year follow-up J. I. O Riordan, 1 A. J. Thompson, 1 D. P. E. Kingsley, 2 D. G. MacManus, 1
More informationORIGINAL CONTRIBUTION. Determinants of Cerebral Atrophy Rate at the Time of Diagnosis of Multiple Sclerosis. imaging (MRI) provides
ORIGINAL CONTRIBUTION Determinants of Cerebral Atrophy Rate at the Time of Diagnosis of Multiple Sclerosis Bas Jasperse, MD; Arjan Minneboo, MD; Vincent de Groot, MD; Nynke F. Kalkers, MD, PhD; Paul E.
More informationABSTRACT Background In patients with isolated syndromes that are clinically suggestive of multiple sclerosis,
A LONGITUDINAL STUDY OF ABNORMALITIES ON MRI AND DISABILITY FROM MULTIPLE SCLEROSIS PETER A. BREX, M.D., OLGA CICCARELLI, M.D., JONATHON I. O RIORDAN, M.D., MICHAEL SAILER, M.D., ALAN J. THOMPSON, M.D.,
More informationORIGINAL CONTRIBUTION. The Natural History of Recurrent Optic Neuritis
ORIGINAL CONTRIBUTION The Natural History of Recurrent Optic Neuritis Istvan Pirko, MD; Lori K. Blauwet, MD; Timothy G. Lesnick, MSc; Brian G. Weinshenker, MD, FRCP(C) Background: Optic neuritis (ON) may
More informationClinical and research application of MRI in diagnosis and monitoring of multiple sclerosis
24-25 February 2016 - Siena, Italy Clinical and research application of MRI in diagnosis and monitoring of multiple sclerosis IMPROVING THE PATIENT S LIFE THROUGH MEDICAL EDUCATION www.excemed.org How
More information1 MS Lesions in T2-Weighted Images
1 MS Lesions in T2-Weighted Images M.A. Sahraian, E.-W. Radue 1.1 Introduction Multiple hyperintense lesions on T2- and PDweighted sequences are the characteristic magnetic resonance imaging (MRI) appearance
More informationNeuroimaging and Other Biomarkers. MRI for Diagnosis, Prognosis and Treatment Decisions in MS
Neuroimaging and Other Biomarkers MRI for Diagnosis, Prognosis and Treatment Decisions in MS Eric Klawiter, MD MSc Massachusetts General Hospital May 30, 2014 Disclosures and Funding Disclosures: Consulting
More informationORIGINAL CONTRIBUTION. Magnetic Resonance Imaging Effects of Interferon Beta-1b in the BENEFIT Study
ORIGINAL CONTRIBUTION Magnetic Resonance Imaging Effects of Interferon in the BENEFIT Study Integrated 2-Year Results Frederik Barkhof, MD, PhD; Chris H. Polman, MD, PhD; Ernst-Wilhelm Radue, MD; Ludwig
More informationRelevance of Hypointense Lesions on Fast Fluid- Attenuated Inversion Recovery MR Images as a Marker of Disease Severity in Cases of Multiple Sclerosis
AJNR Am J Neuroradiol 20:813 820, May 1999 Relevance of Hypointense Lesions on Fast Fluid- Attenuated Inversion Recovery MR Images as a Marker of Disease Severity in Cases of Multiple Sclerosis Marco Rovaris,
More informationCHAIR SUMMIT 7TH ANNUAL #CHAIR2014. Master Class for Neuroscience Professional Development. September 11 13, Westin Tampa Harbour Island
#CHAIR2014 7TH ANNUAL CHAIR SUMMIT Master Class for Neuroscience Professional Development September 11 13, 2014 Westin Tampa Harbour Island Sponsored by #CHAIR2014 Use of MRI in Clinical Decision- Making
More informationSingle-Dose Gadolinium with Magnetization Transfer versus Triple- Dose Gadolinium in the MR Detection of Multiple Sclerosis Lesions
Single-Dose Gadolinium with Magnetization Transfer versus Triple- Dose Gadolinium in the MR Detection of Multiple Sclerosis Lesions J. H. T. M. van Waesberghe, J. A. Castelijns, W. Roser, N. Silver, T.
More informationA Comparison of MR Imaging with Fast-FLAIR, HASTE-FLAIR, and EPI-FLAIR Sequences in the Assessment of Patients with Multiple Sclerosis
AJNR Am J Neuroradiol 20:1931 1938, November/December 1999 A Comparison of MR Imaging with Fast-FLAIR, HASTE-FLAIR, and EPI-FLAIR Sequences in the Assessment of Patients with Multiple Sclerosis Massimo
More informationMRI dynamics of brain and spinal cord in progressive multiple sclerosis
J7ournal of Neurology, Neurosurgery, and Psychiatry 1 996;60: 15-19 MRI dynamics of brain and spinal cord in progressive multiple sclerosis 1 5 D Kidd, J W Thorpe, B E Kendall, G J Barker, D H Miller,
More informationClinically isolated syndromes (CIS) may
RECOGNIZING AND MANAGING THE CLINICALLY ISOLATED SYNDROME* Steven L. Galetta, MD ABSTRACT Clinically isolated demyelinating syndromes, such as optic neuritis, transverse myelitis, and brain-stem disorders,
More informationOptic Neuritis and Multiple Sclerosis
Part I Optic Nerve Chapter 1 Optic Neuritis and Multiple Sclerosis Edward J. Atkins, Valérie Biousse, Nancy J. Newman 1 Core Messages Idiopathic optic neuritis, an isolated inflammatory optic neuropathy
More informationAssociation of asymptomatic spinal cord lesions and atrophy with disability. 5 years after a clinically isolated syndrome
Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome WJ Brownlee 1, DR Altmann 1,2, P Alves Da Mota 1, JK Swanton 1, KA Miszkiel 3, CAM
More informationORIGINAL ARTICLE Thoracic spinal cord lesions are influenced by the degree of cervical spine involvement in multiple sclerosis
(2015) 53, 520 525 & 2015 International Society All rights reserved 1362-4393/15 www.nature.com/sc ORIGINAL ARTICLE Thoracic spinal cord lesions are influenced by the degree of cervical spine involvement
More informationLow sensitivity of McDonald MRI criteria in the diagnosis of multiple sclerosis among Asians
Neurology Asia 2006; 11 : 129 133 Low sensitivity of McDonald MRI criteria in the diagnosis of multiple sclerosis among Asians 1 Heng-Thay CHONG MRCP, 1 Norlisah RAMLI FRCR, 2 Kwang-Ho LEE MD, 2 Byung-Joon
More informationMagnetic resonance imaging in multiple sclerosis
APRIL 2002 103 Magnetic resonance imaging in multiple sclerosis Beside the ability to detect the Olga Ciccarelli and David H. Miller NMR Unit, Institute of Neurology, University College London, Queen Square,
More informationMultiple Sclerosis vs Acute Disseminated Encephalomyelitis in Childhood
Multiple Sclerosis vs Acute Disseminated Encephalomyelitis in Childhood Steven David Brass, MD, Zografos Caramanos, BA, Carlos Santos, MD, Marie-Emmanuelle Dilenge, MD, Yves Lapierre, MD, and Bernard Rosenblatt,
More informationMultiple sclerosis (MS) is an inflammatory disease of the central nervous. Magnetic Resonance Imaging in Multiple Sclerosis
DIAGNOSIS AND MANAGEMENT UPDATE Magnetic Resonance Imaging in Multiple Sclerosis Salvatore Q. Napoli, MD, * Rohit Bakshi, MD * *Partners, Multiple Sclerosis Center, Boston, MA, Center for Neurological
More informationNEW DIAGNOSTIC CRITERIA FOR MULTIPLE SCLEROSIS
NEW DIAGNOSTIC CRITERIA FOR MULTIPLE SCLEROSIS Jeffrey A. Cohen, MD Director, Experimental Therapeutics Mellen MS Center Neurological Institute Cleveland Clinic 2018 Regional MS Summit 30 June 2018 Disclosures
More informationSHORTLY AFTER ITS FIRST DEpiction
OBSERVATION Seven-Tesla Magnetic Resonance Imaging New Vision of Microvascular Abnormalities in Multiple Sclerosis Yulin Ge, MD; Vahe M. Zohrabian, MD; Robert I. Grossman, MD Background: Although the role
More informationMDWISE PRIOR AUTHORIZATION CRITERIA TYSABRI (natalizumab): 300mg/15mL single use vial
MDWISE PRIOR AUTHORIZATION CRITERIA TYSABRI (natalizumab): 300mg/15mL single use vial Formulary Status: Non-Formulary requiring prior authorization PA CRITERIA FOR INITIAL AUTHORIZATION FOR USE IN MULTIPLE
More informationUse of MRI Technology in Determining Prognosis and Tracking Therapeutic Benefit in Multiple Sclerosis
Use of MRI Technology in Determining Prognosis and Tracking Therapeutic Benefit in Multiple Sclerosis Timothy Vollmer, MD Associate Professor of Neurology Yale School of Medicine New Haven, Connecticut
More informationEpidemiology, Diagnosis, Natural History & Clinical Course
Epidemiology, Diagnosis, Natural History & Clinical Course Multiple Sclerosis Immune-mediated, chronic, inflammatory disease precipitated by unknown environmental factors in genetically susceptible individuals
More informationMultiple Sclerosis (MS) is a
The role of interferon beta in multiple sclerosis management David J Rog MRCP, John P Mottershead MRCP, Greater Manchester Neurosciences Centre, Hope Hospital, Stott Lane, Manchester, M6 8HD SPL Multiple
More informationEvolution of Multiple Sclerosis Lesions on Serial Contrast-Enhanced T1-Weighted and Magnetization-Transfer MR Images
AJNR Am J Neuroradiol 20:1939 1945, November/December 1999 Evolution of Multiple Sclerosis Lesions on Serial Contrast-Enhanced T1-Weighted and Magnetization-Transfer MR Images Alex Rovira, Juli Alonso,
More informationNeurological Assessment for Multiple Sclerosis and Extended Disability Scale Score
Neurological Assessment for Multiple Sclerosis and Extended Disability Scale Score This section should only be completed by a neurologist or MD / ROD (Medical Doctor / Resident on Duty) involved in the
More informationORIGINAL CONTRIBUTION. Multiple Sclerosis That Is Progressive From the Time of Onset
ORIGINAL CONTRIBUTION Multiple Sclerosis That Is Progressive From the Time of Onset Clinical Characteristics and Progression of Disability P. B. Andersson, MBChB, DPhil; E. Waubant, MD; L. Gee, MPH; D.
More informationPATIENTS WITH MULTIPLE SCLEROSIS
3 PATIENTS WITH MULTIPLE SCLEROSIS PREFER EARLY DIAGNOSIS Abstract The new diagnostic criteria for multiple sclerosis (MS) allow for a definite diagnosis in earlier stages of disease. Yet, clinicians may
More informationEFNS guidelines on the use of neuroimaging in the management of multiple sclerosis
European Journal of Neurology 2006, 13: 313 325 EFNS TASK FORCE ARTICLE/CME ARTICLE EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis M. Filippi a, M. A. Rocca a, D. L.
More informationT he spinal cord is frequently affected, both pathologically
51 PAPER Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year study W Rashid, G R Davies, D T Chard, C M Griffin, D R Altmann, R Gordon, A J Thompson, D H Miller... See end
More informationORIGINAL CONTRIBUTION. Long-term Follow-up of Acute Partial Transverse Myelitis
ORIGINAL CONTRIBUTION Long-term Follow-up of Acute Partial Transverse Myelitis Bertrand Bourre, MD; Hélène Zéphir, MD; Jean-Claude Ongagna, CRA; Charlotte Cordonnier, MD, PhD; Nicolas Collongues, MD; Stephanie
More informationORIGINAL CONTRIBUTION. Reliability of Classifying Multiple Sclerosis Disease Activity Using Magnetic Resonance Imaging in a Multiple Sclerosis Clinic
ORIGINAL CONTRIBUTION Reliability of Classifying Multiple Sclerosis Disease Activity Using Magnetic Resonance Imaging in a Multiple Sclerosis Clinic Ebru Erbayat Altay, MD; Elizabeth Fisher, PhD; Stephen
More informationEvolution of T 1 black holes in patients with multiple sclerosis imaged monthly for 4 years
DOI: 10.1093/brain/awg182 Advanced Access publication June 23, 2003 Brain (2003), 126, 1782±1789 Evolution of T 1 black holes in patients with multiple sclerosis imaged monthly for 4 years Francesca Bagnato,
More informationNegative prognostic impact of MRI spinal lesions in the early stages of relapsing remitting multiple sclerosis
Original Article Negative prognostic impact of MRI spinal lesions in the early stages of relapsing remitting multiple sclerosis E D Amico, F Patti, C Leone, S Lo Fermo and M Zappia Multiple Sclerosis Journal
More informationChanging EDSS progression in placebo cohorts in relapsing MS:
Changing EDSS progression in placebo cohorts in relapsing MS: A systematic review and meta-regression Christian Röver 1, Richard Nicholas 2, Sebastian Straube 3, Tim Friede 1 1 Department of Medical Statistics,
More informationApplication of the McDonald MRI Criteria in Multiple Sclerosis
Original Article 647 Application of the McDonald MRI Criteria in Multiple Sclerosis Ling-Ling Chan, 1 MBBS, FRCR, FAMS, Yih-Yian Sitoh, 2 MBBS, FRCR, June Chong, 3 MBBS, ABR, Siew-Ju See, 4 MBBS, MRCP,
More informationCorpus callosum index and long-term disability in multiple sclerosis patients
J Neurol (2010) 257:1256 1264 DOI 10.1007/s00415-010-5503-x ORIGINAL COMMUNICATION Corpus callosum index and long-term disability in multiple sclerosis patients Özgür Yaldizli Ramin Atefy Achim Gass Dietrich
More informationDisability and T 2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis
doi:10.1093/brain/awm329 Disability and T 2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis L. K. Fisniku, 1,2 P. A. Brex, 4 D. R. Altmann, 1,5 K. A. Miszkiel, 6 C.
More informationMEDIA BACKGROUNDER. Multiple Sclerosis: A serious and unpredictable neurological disease
MEDIA BACKGROUNDER Multiple Sclerosis: A serious and unpredictable neurological disease Multiple sclerosis (MS) is a complex chronic inflammatory disease of the central nervous system (CNS) that still
More informationMagnetization-Transfer Histogram Analysis of the Cervical Cord in Patients with Multiple Sclerosis
AJNR Am J Neuroradiol 20:1803 1808, November/December 1999 Magnetization-Transfer Histogram Analysis of the Cervical Cord in Patients with Multiple Sclerosis Marco Bozzali, Maria A. Rocca, Giuseppe Iannucci,
More informationLong-Term Changes of Magnetization Transfer Derived Measures from Patients with Relapsing-Remitting and Secondary Progressive Multiple Sclerosis
AJNR Am J Neuroradiol 20:821 827, May 1999 Long-Term Changes of Magnetization Transfer Derived Measures from Patients with Relapsing-Remitting and Secondary Progressive Multiple Sclerosis Maria A. Rocca,
More informationPatologie infiammatorie encefaliche e midollari
Patologie infiammatorie encefaliche e midollari Maria Laura Stromillo Department of Medicine, Surgery and Neuroscience Inflammatory disorders of the CNS NMOSD ADEM Multiple Sclerosis Neuro-Myelitis Optica
More informationShort-Term Correlations between Clinical and MR Imaging Findings in Relapsing-Remitting Multiple Sclerosis
AJNR Am J Neuroradiol 24:75 81, January 2003 Short-Term Correlations between Clinical and MR Imaging Findings in Relapsing-Remitting Multiple Sclerosis Marco Rovaris, Giancarlo Comi, David Ladkani, Jerry
More informationNew Insights on Optic Neuritis in Young People
Cronicon OPEN ACCESS EC OPHTHALMOLOGY Case Study New Insights on Optic Neuritis in Young People Sergio Carmona 1, Sandra Barbosa 1 and Maria Laura Ortube 2 * 1 Department of Neuro-ophthalmology, Hospital
More informationMRI diagnostic criteria for multiple sclerosis: an update
MRI diagnostic criteria for multiple sclerosis: an update Poster No.: C-0285 Congress: ECR 2013 Type: Educational Exhibit Authors: L. Valls Masot, A. M. Quiles Granado, J. Puig Alcántara, L. RamióTorrentà,
More informationReactivation of herpesvirus under fingolimod: A case of severe herpes simplex encephalitis
Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2015 Reactivation of herpesvirus under fingolimod: A case of severe herpes
More informationMRI in MS. MRI in multiple sclerosis. MS T2 Lesions: Pathology. Brain lesions Morphology Matters. Sagittal FLAIR Morphology Matters
MRI in multiple sclerosis MRI in MS Rohit Bakshi, MD, MA Breakstone Professor of Neurology & Radiology Director, Laboratory for Neuroimaging Research Senior Neurologist, MS Center Brigham & Women s Hospital
More informationThe Role of MRI in Multiple Sclerosis
September 2006 The Role of MRI in Multiple Sclerosis David Cochran, Harvard Medical School Year IV Meet our patient WM 49yoF presents to Multiple Sclerosis Clinic for follow-up regarding worsening symptoms
More informationClinical, Laboratory and Radiological Predictors of Outcome in Relapsing Remitting Multiple Sclerosis
Ashraf A. Aboelsafa et al. Clinical, Laboratory and Radiological Predictors of Outcome in Relapsing Remitting Multiple Sclerosis Ashraf A. Aboelsafa, Ehab A. Elseidy, Ehab S. Mohammed Department of Neuropsychiatry,
More informationNeuroradiology Original Research
MRI of Multiple Sclerosis Lesions Neuroradiology Original Research Ender Uysal 1 Sukru Mehmet Erturk 1 Hakan Yildirim 1 Feray Seleker 2 Muzaffer Basak 1 Uysal E, Erturk SM, Yildirim H, et al. Keywords:
More informationMRI in Multiple Sclerosis Features of Cerebral Atrophy with special focus on Multiple Sclerosis. E.W. Radue K. Bendfeldt Till Sprenger
MRI in Multiple Sclerosis Features of Cerebral Atrophy with special focus on Multiple Sclerosis E.W. Radue K. Bendfeldt Till Sprenger Medical Image Analysis Center University Hospital Basel www. miac.ch
More informationMR imaging has played an important role in contributing
CONSENSUS STATEMENT Standardized MR Imaging Protocol for Multiple Sclerosis: Consortium of MS Centers Consensus Guidelines J.H. Simon D. Li A. Traboulsee P.K. Coyle D.L. Arnold F. Barkhof J.A. Frank R.
More informationHot Topics Multiple Sclerosis. Natalie Parks, MD, FRCPC Assistant Professor, Dalhousie University June 27, 2018
Hot Topics Multiple Sclerosis Natalie Parks, MD, FRCPC Assistant Professor, Dalhousie University June 27, 2018 Disclosures Natalie Parks has received compensation from Biogen, EMD Serono, Roche, and Sanofi
More informationGuideline for the use of beta-interferons in patients with multiple sclerosis a South African proposal
GUIDELINE Guideline for the use of beta-interferons in patients with multiple sclerosis a South African proposal Multiple Sclerosis Advisory Committee of the Neurological Association of South Africa (NASA)
More informationClinical Correlations of Brain Lesion Distribution in Multiple Sclerosis
JOURNAL OF MAGNETIC RESONANCE IMAGING 29:768 773 (2009) Original Research Clinical Correlations of Brain Lesion Distribution in Multiple Sclerosis M.M. Vellinga, MD, 1 * J.J.G. Geurts, PhD, 2,3 E. Rostrup,
More informationDiagnostic Criteria, Clinical Courses, and Rating Scales in MS
Diagnostic Criteria, Clinical Courses, and Rating Scales in MS Introduction and Objectives Introduction This module will focus on diagnostic tools utilized in randomized clinical trials (RCTs) in MS. Diagnostic
More informationProvider Led Entity. CDI Quality Institute PLE Multiple Sclerosis (MS) AUC
Provider Led Entity CDI Quality Institute PLE Multiple Sclerosis (MS) AUC Appropriateness of advanced imaging procedures* in patients with the following clinical presentations or diagnoses: 09/04/2018
More informationProgressive Multiple Sclerosis
Progressive Multiple Sclerosis Definitions, Clinical Course and Emerging Therapies M. Mateo Paz Soldán, MD, PhD Neurology Service, VA Salt Lake City HCS Assistant Professor of Neurology, University of
More informationQuantitative divusion weighted magnetic resonance imaging, cerebral atrophy, and disability in multiple sclerosis
318 Division of Clinical Neurology, Faculty of Medicine, University Hospital, Queen s Medical Centre, Nottingham NG7 2UH, UK M Wilson X Lin B P Turner L D Blumhardt Division of Academic Radiology P S Morgan
More informationCite this article as: BMJ, doi: /bmj c (published 24 March 2006)
Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review Penny Whiting, Roger Harbord, Caroline Main, Jonathan J Deeks, Graziella Filippini, Matthias Egger, Jonathan
More informationHelpful Information for evaluation of new neurological symptoms in patients receiving TYSABRI
Helpful Information for evaluation of new neurological symptoms in patients receiving TYSABRI This information is provided as an educational resource for healthcare providers and should be considered current
More informationPATIENT INFORMATION: Patient Surname First Name Middle Initial Sex Date of Birth Alberta Personal Health Number M / F Year Month Day
Applicant must be covered on an Alberta Government sponsored drug program. Page 1 of 6 PATIENT INFORMATION: Patient Surname First Name Middle Initial Sex Date of Birth Alberta Personal Health Number M
More informationAnalysis of prognostic significance of clinical and paraclinical indices in case of different types of acute disseminated encephalomyelitis course.
1 2 Analysis of prognostic significance of clinical and paraclinical indices in case of different types of acute disseminated encephalomyelitis course. 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
More informationMULTIPLE SCLEROSIS IN Managing the complexity of multiple sclerosis. Olga Ciccarelli and Alan Thompson
MULTIPLE SCLEROSIS IN 2015 Managing the complexity of multiple sclerosis Olga Ciccarelli and Alan Thompson The application of imaging biomarkers has provided new insights into the mechanisms of damage
More informationNeuroradiological, clinical and genetic characterization of new forms of hereditary leukoencephalopathies
Neuroradiological, clinical and genetic characterization of new forms of hereditary leukoencephalopathies Principal Investigator: Dr. Donatella Tampieri, MD, FRCPC, Department of Neuroradiology, Montreal
More informationIdiopathic Inflammatory Demyelinating Diseases of the Brainstem
Idiopathic Inflammatory Demyelinating Diseases of the Brainstem 1 A. Rovira-Cañellas, 2 A. Rovira-Gols, 1 J. Sastre-Garriga, 1 C. Auger, 1 J. Munuera, 1 X. Montalban 1 Hospital Vall d Hebron, Barcelona.
More informationEarly development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes
DOI: 10.1093/brain/awh126 Brain (2004), 127, 1101±1107 Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes
More informationMRI and differential diagnosis in patients suspected of having MS
Andrea Falini Italy MRI and differential diagnosis in patients suspected of having MS IMPROVING THE PATIENT S LIFE THROUGH MEDICAL EDUCATION www.excemed.org Outline of presentation - Diagnostic criteria
More informationPrimary progressive multiple sclerosis: a 5-year clinical and MR study
DOI: 10.1093/brain/awg261 Advanced Access publication August 5, 2003 Brain (2003), 126, 2528±2536 Primary progressive multiple sclerosis: a 5-year clinical and MR study G. T. Ingle, 1 V. L. Stevenson,
More informationPediatric acute demyelinating encephalomyelitis in Denmark: a nationwide population-based study
Pediatric acute demyelinating encephalomyelitis in Denmark: a nationwide population-based study Magnus Spangsberg Boesen November, 2016 Supervisors: P. Born, P. Uldall, M. Blinkenberg, M. Magyari, F. Sellebjerg
More informationORIGINAL CONTRIBUTION. Magnetization Transfer Magnetic Resonance Imaging and Clinical Changes in Patients With Relapsing-Remitting Multiple Sclerosis
ORIGINAL CONTRIBUTION Magnetization Transfer Magnetic Resonance Imaging and Clinical Changes in Patients With Relapsing-Remitting Multiple Sclerosis Celia Oreja-Guevara, MD; Arnaud Charil, MSc; Domenico
More informationOvid: Barkhof: Neurology, Volume 49(6).December Copyright 1997 American Academy of Neurology. Volume 49(6) December 1997 pp
Page 1 of 11 Copyright 1997 American Academy of Neurology Volume 49(6) December 1997 pp 1682-1688 Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis [Articles]
More informationORIGINAL CONTRIBUTION. Multiple Sclerosis Risk After Optic Neuritis. inflammatory disorder of the optic nerve, typically
ORIGINAL CONTRIBUTION Multiple Sclerosis Risk After Optic Neuritis Final Optic Neuritis Treatment Trial Follow-up The Optic Neuritis Study Group Objective: To assess the risk of developing multiple sclerosis
More informationClinical trials of multiple sclerosis monitored with enhanced MRI: new sample size calculations based on large data sets
494 Neuroimaging Research Unit, Department of Neuroscience, Scientific Institute Ospedale San RaVaele, University of Milan, Via Olgettina 6, 2132 Milan, Italy M P Sormani M Rovaris M Filippi Clinical Trials
More informationMagnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis
doi:10.1093/brain/awh654 Brain (2005), 128, 2911 2925 Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis K. T. M. Fernando, 1,3 D. J. Tozer, 1 K. A. Miszkiel,
More informationFormation of lesions in multiple sclerosis (MS) comprises a
ORIGINAL RESEARCH D.S. Meier H.L. Weiner C.R.G. Guttmann MR Imaging Intensity Modeling of Damage and Repair In Multiple Sclerosis: Relationship of Short-Term Lesion Recovery to Progression and Disability
More informationMyelitis. Case 2. History. Examination. Mahtab Ghadiri
Case 2 Myelitis Mahtab Ghadiri History A 42-year-old man presented to the emergency department with altered sensation in the lower limbs and difficulty ambulating. He first noted paresthesia in his feet
More informationChapter 3.3. MRI Predictors for disability at 5 years after the diagnosis of MS
MRI Predictors for disability at 5 years after the diagnosis of MS Arjan Minneboo, Bas Jasperse, Frederik Barkhof, Bernard M.J. Uitdehaag, Dirk L. Knol, Vincent de Groot, Chris H. Polman, and Jonas A.
More informationcontemporary ne PRACTICAL NEUROLOGY
106 Pract Neurol: first published as 10.1046/j.1474-7766.2001.00006.x on 1 December 2001. Downloaded from http://pn.bmj.com/ contemporary ne on 7 April 2019 by guest. Protected by copyright. eurological
More informationThe Low Sensitivity of Fluid-Attenuated Inversion-Recovery MR in the Detection of Multiple Sclerosis of the Spinal Cord
The Low Sensitivity of Fluid-Attenuated Inversion-Recovery MR in the Detection of Multiple Sclerosis of the Spinal Cord Mark D. Keiper, Robert I. Grossman, John C. Brunson, and Mitchell D. Schnall PURPOSE:
More informationProgram Highlights. A multidisciplinary AAN working group identified areas for improvement in the diagnosis and management of patients with MS
CasePerspectives: Illuminating Dark Pathways in Complex MS Cases Program Highlights Stephen Krieger, MD Associate Professor of Neurology Corinne Goldsmith Dickinson Center for MS Director, Neurology Residency
More informationDiagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria Alan J Thompson, Brenda L Banwell, Frederik Barkhof, William M Carroll, Timothy Coetzee, Giancarlo Comi, Jorge Correale, Franz Fazekas,
More informationReview Article Outcome Measures in Relapsing-Remitting Multiple Sclerosis: Capturing Disability and Disease Progression in Clinical Trials
Multiple Sclerosis International, Article ID 262350, 13 pages http://dx.doi.org/10.1155/2014/262350 Review Article Outcome Measures in Relapsing-Remitting Multiple Sclerosis: Capturing Disability and Disease
More informationPeriventricular T2-hyperintense lesions: does the number matter in CIS?
Periventricular T2-hyperintense lesions: does the number matter in CIS? Dott.ssa Caterina Lapucci Department of Neuroscience, Rehabilitation, Ophthalmology. Genetics, Maternal and Child Health (DINOGMI)
More informationMedscape: What do you see as the main clinical implications of your results?
http://www.medscape.com/px/viewindex/more?bucket=columns§ionid=2011 Treatment Optimization for Multiple Sclerosis: An Expert Interview With Mark Freedman, MD Posted 11/10/2004 Editor's Note: Multiple
More informationORIGINAL CONTRIBUTION. Normal-Appearing Brain T1 Relaxation Time Predicts Disability in Early Primary Progressive Multiple Sclerosis
ORIGINAL CONTRIBUTION Normal-Appearing Brain T1 Relaxation Time Predicts Disability in Early Primary Progressive Multiple Sclerosis Francesco Manfredonia, MD; Olga Ciccarelli, PhD; Zhaleh Khaleeli, MRCP;
More informationWhite matter diseases affecting the corpus callosum; demyelinating and metabolic diseases
White matter diseases affecting the corpus callosum; demyelinating and metabolic diseases Poster No.: C-0199 Congress: ECR 2011 Type: Educational Exhibit Authors: J. H. Yoo; Seoul/KR Keywords: Neuroradiology
More informationThe Multiple Sclerosis Lesion Checklist
The Multiple Sclerosis Lesion Checklist A clinician s guide to evaluating brain MRI in a patient with improbable multiple sclerosis. By Ilya Kister, MD, FAAN Paraphrasing W.B. Matthews about dizziness,
More informationMagnetic Resonance Imaging of Neuromyelitis Optica (Devic s Syndrome)
J Radiol Sci 2012; 37: 45-50 Magnetic Resonance Imaging of Neuromyelitis Optica (Devic s Syndrome) Chien-Chuan Huang Tai-Yuan Chen Tai-Ching Wu Yu-Kun Tsui Te-Chang Wu Wen-Sheng Tzeng Chien-Jen Lin Department
More informationSupplementary Online Content
Supplementary Online Content Schlaeger R, Papinutto N, Zhu AH, et al. Association between thoracic spinal cord gray matter atrophy and disability in multiple sclerosis. JAMA Neurol. Published online June
More informationNIH Public Access Author Manuscript Arch Neurol. Author manuscript; available in PMC 2009 June 1.
NIH Public Access Author Manuscript Published in final edited form as: Arch Neurol. 2008 June ; 65(6): 727 732. Multiple Sclerosis Risk after Optic Neuritis: Final Optic Neuritis Treatment Trial Follow-Up
More informationLong-term results of the first line DMT depend on the presence of minimal MS activity during first years of therapy: data of 15 years observation
Boyko Multiple Sclerosis and Demyelinating Disorders (2016) 1:14 DOI 10.1186/s40893-016-0015-x Multiple Sclerosis and Demyelinating Disorders RESEARCH ARTICLE Open Access Long-term results of the first
More informationOpen Access Width of 3. Ventricle: Reference Values and Clinical Relevance in a Cohort of Patients with Relapsing Remitting Multiple Sclerosis
Send Orders of Reprints at reprints@benthamscience.net The Open Neurology Journal, 2013, 7, 11-16 11 Open Access Width of 3. Ventricle: Reference Values and Clinical Relevance in a Cohort of Patients with
More informationMultiple sclerosis (MS) is a disabling chronic demyelinating disease
Diagn Interv Radiol 2010; 16:106 111 Turkish Society of Radiology 2010 NEURORADIOLOGY ORIGINAL ARTICLE Imaging of active multiple sclerosis plaques: efficiency of contrast-enhanced magnetization transfer
More informationT1- vs. T2-based MRI measures of spinal cord volume in healthy subjects and patients with multiple sclerosis
Kim et al. BMC Neurology (2015) 15:124 DOI 10.1186/s12883-015-0387-0 RESEARCH ARTICLE Open Access T1- vs. T2-based MRI measures of spinal cord volume in healthy subjects and patients with multiple sclerosis
More informationMRI Atlas of MS Lesions
MRI Atlas of MS Lesions M. A. Sahraian, E.-W. Radue MRI Atlas of MS Lesions With the collaboration of A. Gass, S. Haller, L. Kappos, J. Kesselring, J.-I. Kira, K. Weier 123 Prof. Dr. med. Mohammad Ali
More information